Literature DB >> 2529343

Soluble cytokine receptors are present in normal human urine.

D Novick1, H Engelmann, D Wallach, M Rubinstein.   

Abstract

Affinity chromatography of crude human urinary proteins on either human rIL-6, human rIFN-gamma, or anti-IFN-gamma-R mAb yielded the two respective soluble receptors in significant quantities. A single sequence of 30 amino acid residues was obtained by NH2-terminal microsequencing of the protein peak purified in tandem by affinity chromatography on an IL-6 column and reversed-phase HPLC. This sequence was identical to the predicted NH2-terminal sequence of IL-6-R as previously reported. Analysis of the eluted proteins from both IFN-gamma and anti-IFN-gamma-R columns by inhibition of solid phase RIA, ELISA, SDS-PAGE, and Western blotting proved the existence of soluble IFN-gamma-R in normal urine. Our finding, together with the already known presence of urinary TNF binding proteins and a soluble IL-2-R both in plasma and in urine, indicates that release of soluble cytokine receptors into body fluids is a general phenomenon that occurs under normal physiological conditions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2529343      PMCID: PMC2189483          DOI: 10.1084/jem.170.4.1409

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  13 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels.

Authors:  B R Oakley; D R Kirsch; N R Morris
Journal:  Anal Biochem       Date:  1980-07-01       Impact factor: 3.365

3.  Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor.

Authors:  K Yamasaki; T Taga; Y Hirata; H Yawata; Y Kawanishi; B Seed; T Taniguchi; T Hirano; T Kishimoto
Journal:  Science       Date:  1988-08-12       Impact factor: 47.728

4.  The human interferon-gamma receptor. Purification, characterization, and preparation of antibodies.

Authors:  D Novick; P Orchansky; M Revel; M Rubinstein
Journal:  J Biol Chem       Date:  1987-06-25       Impact factor: 5.157

5.  A tumor necrosis factor binding protein is present in human biological fluids.

Authors:  C Peetre; H Thysell; A Grubb; I Olsson
Journal:  Eur J Haematol       Date:  1988-11       Impact factor: 2.997

6.  Monoclonal antibodies to the human interferon-gamma receptor: blocking of the biological activities of interferon-gamma and purification of the receptor.

Authors:  D Novick; D G Fischer; Z Reiter; Z Eshhar; M Rubinstein
Journal:  J Interferon Res       Date:  1989-06

7.  Quantitation of the soluble receptor of human T lymphocytes for sheep erythrocytes by electroimmunodiffusion in the serum of patients with cancer, uremia and leprosy.

Authors:  N C Moura; I M Longo; L A Bernd; N F Mendes
Journal:  Experientia       Date:  1983-03-15

8.  Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.

Authors:  L A Rubin; C C Kurman; M E Fritz; W E Biddison; B Boutin; R Yarchoan; D L Nelson
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

9.  Identification of soluble Fc receptors in mouse serum and the conditioned medium of stimulated B cells.

Authors:  E Pure; C J Durie; C K Summerill; J C Unkeless
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

10.  A human inhibitor of tumor necrosis factor alpha.

Authors:  P Seckinger; S Isaaz; J M Dayer
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

View more
  76 in total

Review 1.  Cytokine receptors: structure and signal transduction.

Authors:  B M Foxwell; K Barrett; M Feldmann
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

Review 2.  The extracellular regulation of growth factor action.

Authors:  R Flaumenhaft; D B Rifkin
Journal:  Mol Biol Cell       Date:  1992-10       Impact factor: 4.138

Review 3.  Cytokines, receptors, and inhibitors.

Authors:  G Gehr; T Braun; W Lesslauer
Journal:  Clin Investig       Date:  1992-01

4.  Organization of the murine and human interleukin-7 receptor genes: two mRNAs generated by differential splicing and presence of a type I-interferon-inducible promoter.

Authors:  C M Pleiman; S D Gimpel; L S Park; H Harada; T Taniguchi; S F Ziegler
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

5.  Altered interleukin-2 receptor alpha-chain is expressed in human T-cell leukaemia virus type-I-infected T-cell lines and human peripheral blood mononuclear cells of adult T-cell leukaemia patients through an alternative splicing mechanism.

Authors:  S Horiuchi; Y Koyanagi; Y Tanaka; M Waki; A Matsumoto; Y W Zhou; M Yamamoto; N Yamamoto
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

6.  Low follicular fluid IL-6 levels in IVF patients are associated with increased likelihood of clinical pregnancy.

Authors:  Tugba Altun; Sangita Jindal; Keri Greenseid; Jun Shu; Lubna Pal
Journal:  J Assist Reprod Genet       Date:  2010-11-03       Impact factor: 3.412

7.  Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis.

Authors:  F De Benedetti; M Massa; P Pignatti; S Albani; D Novick; A Martini
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

8.  Concentration of fetal plasma and amniotic fluid interleukin-1 in pregnancies complicated by preterm prelabour amniorrhexis.

Authors:  S G Carroll; A Abbas; Y Ville; N Meher-Homji; K H Nicolaides
Journal:  J Clin Pathol       Date:  1995-04       Impact factor: 3.411

9.  A soluble, high-affinity, interleukin-4-binding protein is present in the biological fluids of mice.

Authors:  R Fernandez-Botran; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

Review 10.  Mechanisms of action of bacillus Calmette-Guérin in the treatment of superficial bladder cancer.

Authors:  J J Patard; D K Chopin; L Boccon-Gibod
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.